D-mannose suppresses macrophage IL-1β production

  • Nat Commun. 2020 Dec 11;11(1):6343. doi: 10.1038/s41467-020-20164-6.
Simone Torretta  1 ,  Alessandra Scagliola  1 ,  Luisa Ricci  1 ,  Francesco Mainini  1 ,  Sabrina Di Marco  1 ,  Ivan Cuccovillo  2 ,  Anna Kajaste-Rudnitski  2 ,  David Sumpton  3 ,  Kevin M Ryan  3 ,  Simone Cardaci  4
Affiliations
  • 1. Cancer Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
  • 2. San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
  • 3. CRUK Beatson Institute, Glasgow, UK.
  • 4. Cancer Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy. [email protected].
Abstract

D-mannose is a monosaccharide approximately a hundred times less abundant than glucose in human blood. Previous studies demonstrated that supraphysiological levels of D-mannose inhibit tumour growth and stimulate regulatory T cell differentiation. It is not known whether D-mannose metabolism affects the function of non-proliferative cells, such as inflammatory Macrophages. Here, we show that D-mannose suppresses LPS-induced macrophage activation by impairing IL-1β production. In vivo, mannose administration improves survival in a mouse model of LPS-induced endotoxemia as well as decreases progression in a mouse model of DSS-induced Colitis. Phosphomannose isomerase controls response of LPS-activated Macrophages to D-mannose, which impairs Glucose Metabolism by raising intracellular mannose-6-phosphate levels. Such alterations result in the suppression of succinate-mediated HIF-1α activation, imposing a consequent reduction of LPS-induced Il1b expression. Disclosing an unrecognized metabolic hijack of macrophage activation, our study points towards safe D-mannose utilization as an effective intervention against inflammatory conditions.

Products